Abstract
Objective
Polysomnographic investigations have shown an unspecific association between cluster headache and obstructive sleep apnea syndrome. The aim of this study was to investigate this association in a cluster episode compared with a symptom free interval, and to further characterize this association.
Methods
We investigated 42 patients with episodic (n = 26) or chronic (n = 16) cluster headache by means of polygraphic screening for sleep apnea and compared the data to 28 healthy control subjects matched according to age, sex, and BMI. The patients with episodic cluster headache were screened twice, once in a cluster episode and once in a symptom free interval.
Results
Patients with active cluster headache showed a significantly higher respiratory distress index (8.6 ± 16.0) compared with healthy control subjects (3.4 ± 2.1; p = 0.002). More patients fulfilled the criteria for an obstructive sleep apnea syndrome (29%) than control subjects (7%; p = 0.018). Patients only, but not the control subjects, had central apneas. These differences were only significant when measured during an active cluster episode but not during a symptom free interval.
Conclusion
Cluster headache is associated with a sleep apnea syndrome only in the active cluster episode. The increased rate of central apneas might be a result of involvement of the hypothalamus in the pathophysiology of cluster headache. Out of five anecdotal cases treated with nasal continuous positive airway pressure, only one patient showed benefit with respect to cluster headache attack frequency.
Keywords
Introduction
The hypothalamus plays a pivotal role in the pathophysiology of cluster headache (1). There is strong evidence that cluster headache is a biorhythmic disorder and, in particular, is linked to sleep. Sleep disorders such as insomnia (2) seem to be common among patients with cluster headache. Previous polysomnographic investigations showed an association between both the occurrence of cluster headache attacks during REM sleep and an association with obstructive sleep apnea syndrome (OSAS) (3–16). The association of cluster headache attacks with REM sleep, however, is controversial; recent polysomnographic studies could not show such an association (17,18). Most of these studies did not include healthy control subjects and did not differentiate between different types of sleep apnea and the different episodes of cluster headache.
The aim of this study was to investigate the association between cluster headache and sleep apnea syndrome in a cluster episode compared with a symptom free interval and healthy control subjects. Furthermore, we aimed to characterize the sleep apneas in cluster headache to conclude on the pathophysiological mechanisms. Therefore, we matched the patients and the healthy control subjects for body mass index (BMI) to control for this variable, which is an important factor in the pathophysiology of OSAS. Finally, we offered patients treatment by nasal continuous positive airway pressure (nCPAP) if they showed OSAS to evaluate the efficacy of this treatment on cluster headache. However, this offer was not part of the study protocol but a routine clinical procedure.
Patients and methods
Patients
We enrolled consecutive patients with active cluster headache by means of polygraphic screening for sleep apnea (MESAM). As a control group, we included healthy subjects, matched according to age, sex, and BMI. Attempts were made to screen patients with episodic cluster headache twice, once in a cluster episode and once in a symptom free interval. All patients were recruited from the headache outpatient clinic of the Department of Neurology, University of Münster, Germany, and from the Department of Neurology, Krankenhaus Lindenbrunn, Germany. They gave informed consent before inclusion into the study. The diagnosis of cluster headache was made according to the International Headache Society (IHS) criteria, 2nd edition (19).
Data registration
Before onset of sleep recording, patients filled in the Epworth sleepiness scale (20). Then, the MESAM device was provided and explained to the patients. We registered the following biosignals: flow at mouth and nose; oxygen saturation; thoracic and abdominal expansion (breathing excursion); heart rate; electrocardiogram; movements/body position; pressure of CPAP (if applicable). Ten patients used the MESAM device in the hospital as inpatients. The remaining patients and all control subjects used the device at home.
We evaluated hypopneas and apneas. A hypopnea was defined as an incomplete decrease of nasal and/or oral flow for more than 10 seconds in combination with a reduction of tidal volume by more than 50%. An apnea was defined as a complete stop of nasal and oral flow with a reduction of tidal volume by at least 20% for more than 10 seconds combined with a reduction of oxygen saturation by at least 4%. A sleep apnea syndrome was diagnosed when the number of hypopneas and apneas was more than five per hour (so called respiratory distress index, RDI) during sleep. Furthermore, we differentiated between obstructive and central apneas. An obstructive apnea was defined as a stop of nasal and oral flow combined with maintained thoracic and/or diaphragmal breathing activity. A central apnea was defined as a stop of nasal and oral flow with missing activity in the thoracic and diaphragmal muscles. Also, the desaturation index was evaluated (i.e. decrease of oxygen saturation by 4% or more for at least 10 seconds) (21).
The data curves registered by the device were visually re-analyzed. Then the following data were included in the analysis: RDI (sum of apnea and hypopnea index); apnea index (separately for obstructive and central apneas); hypopnea index; desaturation index; mean and minimal oxygen saturation; heart rate; time of oxygen saturation under 90% (Ct_90); percentage of patients with obstructive sleep apnea syndrome (i.e. RDI for obstructive apneas >5/h); percentage of central sleep apnea syndrome (i.e. RDI for central apneas >5/h).
Statistics
For statistical analysis, the program SPSS 15.0 was used. Data are presented as arithmetic mean with standard deviation or as percentage. We used non-parametric testing. The Mann-Whitney U test and the Wilcoxon test were carried out to analysis differences between quantitative data. Chi-square test and Fisher’s exact test (if applicable) were used for the analysis of qualitative data. Significance level was set at p = 0.05.
Results
Clinical and demographic data of patients with cluster headache and healthy control subjects.
Values are given as mean ± standard deviation unless otherwise specified. p Values were calculated according to Mann-Whitney U test, and Chi-square test or Fisher’s exact test for qualitative parameters.
Sleep parameters for all patients with active cluster headache (i.e. cluster episode and chronic cluster) and for healthy control subjects.
p Values were calculated according to Mann-Whitney U test, and Chi-square test or Fisher’s exact test for qualitative parameters.
Sleep parameters for all patients with episodic cluster headache who could be examined during and outside the episode (n = 14).
p Values were calculated according to Wilcoxon test, and Chi-square test or Fisher’s exact test for qualitative parameters.
Sleep parameters for episodic cluster headache patients during the episode versus chronic cluster headache patients.
p Values were calculated according to Wilcoxon test, and Chi-square test or Fisher’s exact test for qualitative parameters.
We also evaluated the data of MESAM recordings during a night with cluster headache attacks versus no cluster headache attacks. There were no significant differences in all parameters (data not shown).
Five patients (two episodic, three chronic) were willing to undergo nCPAP treatment during the night for 1 week. They were asked to record the number of cluster headache attacks during this week, which was compared with the average number of cluster headache attacks per week during the baseline. There was only a mild decrease from 18.4 ± 2.8 to 14.0 ± 2.7. Only one patient reported a meaningful reduction from 21 to 9 attacks per week, the other four patients did not report any subjective benefit. As the number of patients was small and this treatment was not part of the study protocol, we did not perform any further statistical analysis.
Discussion
Our results confirm an association of active cluster headache with sleep apnea syndrome. This association can be observed in the cluster headache episode but not in the cluster headache interval. There were some trends suggesting that the apnea syndrome is more severe in chronic cluster than in active episodic cluster headache. Furthermore, we could show that cluster headache patients not only have obstructive apneas, but also central apneas.
We matched our patients according to BMI, because we wanted to exclude this factor in the analysis. A high BMI is one of the major reasons for OSAS, and is often observed in cluster headache patients. It has also been shown to be one of the major risk factors for OSAS even in cluster headache patients (11). Our finding of a significantly increased RDI and of other pathological sleep parameters only during the cluster episode but not in the interval, suggests a specific role of the cluster headache pathophysiology in the occurrence of sleep apneas. Therefore, we do not believe that apneas in cluster headache are the consequence only of a high BMI or of increased rate of smoking.
The finding of central apneas in cluster headache is also an argument for a specific role of cluster headache pathophysiology in the occurrence of sleep apneas in this disorder (16). To our knowledge, we could demonstrate for the first time that cluster headache patients not only have obstructive sleep apneas, but also central apneas which are the result of a central dysregulation of ventilation. It is likely that the hypothalamic functions and, in particular, orexin metabolism, which have been shown to be involved in cluster headache as the major regulation mechanisms (22), are also dysfunctional in regulation of sleep in cluster headache patients. In fact, observational studies have recently shown that deep brain stimulation of the posterior hypothalamus not only decreases the severity of cluster headache, but also regulates sleep pattern in refractory cluster headache patients (23,24).
In our study, only 29% of the patients fulfilled the criteria for OSAS, very similar to two other studies (9,14), whereas different studies reported up to 80% of the cluster patients having an RDI higher than five (7,10). It is important to consider whether somnographic measures were performed during the cluster episode or during the cluster interval, and how the evaluation of OSAS was defined, before comparing data from different studies on sleep apnea in cluster headache. Furthermore, if we add the central apnea syndrome patients to the OSAS patients, this results in about 40% of all patients having a sleep apnea syndrome during active cluster headache.
Some previous studies suggested that nocturnal nCPAP treatment can lead to an improvement of cluster headache (6–8,25); other studies did not find a relevant improvement of chronic headache types, including cluster headache with OSAS by nCPAP treatment (14). Prospective controlled studies, however, are still missing.
Interestingly, the Epworth sleepiness scale score was not different between cluster headache patients and healthy control subjects, and between the different cluster headache phases. This means that cluster headache does not go along with increased daytime sleepiness, although cluster headache is associated with insomnia (2). This also points to a specific sleep regulation in cluster headache.
The strength of our study is the comparison of active versus non-active cluster headache, which has been shown to be the most relevant factor for the association of cluster headache and sleep apneas. Another strength is the careful evaluation of apnea phases, making it possible to differentiate between obstructive and central apneas. Our study has also some limitations. First, we controlled for BMI to exclude this anatomic factor as a confounder on the occurrence of sleep apnea, but not for other confounders such as alcohol consumption. Second, we only measured one night and not two nights as is often recommended in sleep studies. It might be that we did not diagnose all patients with sleep apneas or that we diagnosed some patients with sleep apnea who normally do not have sleep related breathing disorders. Third, we did not control for smoking, which was found to be significantly different between cluster headache patients and control subjects in our study, not only with respect to frequency but also to amount of pack years. Smoking could be an additional risk factor for sleep apneas and explain at least a part of the increased frequency of sleep apneas in cluster headache. Finally, we did not perform complete polysomnography in our patients. Therefore, we are not able to analyze the sleep stages and the association with REM sleep or other events during sleep.
Clinical implications
Cluster headache is associated with both obstructive sleep apnea syndrome and central sleep apnea syndrome. The association is only detectable during the cluster episode or in chronic cluster headache but not in the cluster interval. There are merely differences between active episodic cluster headache and chronic cluster headache with respect to sleep parameters. We found no evidence that nCPAP treatment is efficacious in cluster headache associated with OSAS.
Footnotes
Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Conflict of interest
None declared.
